Plasma antithrombin elevations in buccal varidase-treated patients

Innerfield, I.; Goldbloom, A.A.; Boyd, L.J.

Surgery 43(6): 956-958

1958


ISSN/ISBN: 0039-6060
PMID: 13543671
Document Number: 9617
1. Plasma antithrombin was determined in 18 hospitalized patients under active, uninterrupted buccal Varidase treatment for periods varying from 1 to 34 weeks. 2. Following the first few days of buccal Varidase medication the plasma antithrombin activity rose. The range of antithrombin elevation was from 10 to 31 per cent.

Document emailed within 1 workday
Secure & encrypted payments

Plasma antithrombin elevations in buccal varidase-treated patients